These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32641713)

  • 1. Oxidized ATM promotes breast cancer stem cell enrichment through energy metabolism reprogram-mediated acetyl-CoA accumulation.
    Yang D; Peng M; Hou Y; Qin Y; Wan X; Zhu P; Liu S; Yang L; Zeng H; Jin T; Qiu Y; Li Q; Liu M
    Cell Death Dis; 2020 Jul; 11(7):508. PubMed ID: 32641713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis.
    Peng M; Yang D; Hou Y; Liu S; Zhao M; Qin Y; Chen R; Teng Y; Liu M
    Cell Death Dis; 2019 Mar; 10(3):228. PubMed ID: 30850587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized ATM governs stemness of breast cancer stem cell through regulating ubiquitylation and acetylation switch.
    Zhou X; Liu X; Wan X; Xu M; Wang R; Yang D; Peng M; Jin T; Tang R; Liu M; Hou Y
    Biochem Biophys Res Commun; 2024 Jan; 691():149243. PubMed ID: 38016338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
    Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
    EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
    Hu J; Lai Y; Huang H; Ramakrishnan S; Pan Y; Ma VWS; Cheuk W; So GYK; He Q; Geoffrey Lau C; Zhang L; Cho WCS; Chan KM; Wang X; Rebecca Chin Y
    Br J Cancer; 2022 Jan; 126(1):57-71. PubMed ID: 34718356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells.
    Xu P; Sun Y; Song Y; Jiao J; Shen B; Li W; Jiang C; Li Y; Zhang X; Yu J; Fu L; Guo X
    Med Mol Morphol; 2020 Dec; 53(4):210-220. PubMed ID: 32067111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.
    Gagliardi M; Pitner MK; Park J; Xie X; Saso H; Larson RA; Sammons RM; Chen H; Wei C; Masuda H; Chauhan G; Kondo K; Tripathy D; Ueno NT; Dalby KN; Debeb BG; Bartholomeusz C
    Sci Rep; 2020 May; 10(1):8537. PubMed ID: 32444778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
    Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
    Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.
    Chu J; Li Y; Fan X; Ma J; Li J; Lu G; Zhang Y; Huang Y; Li W; Huang X; Fu Z; Yin Y; Yuan H
    Cell Physiol Biochem; 2018; 48(2):593-604. PubMed ID: 30021199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair.
    Liang DH; Choi DS; Ensor JE; Kaipparettu BA; Bass BL; Chang JC
    Cancer Lett; 2016 Jul; 376(2):249-58. PubMed ID: 27060208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination.
    Sivanand S; Rhoades S; Jiang Q; Lee JV; Benci J; Zhang J; Yuan S; Viney I; Zhao S; Carrer A; Bennett MJ; Minn AJ; Weljie AM; Greenberg RA; Wellen KE
    Mol Cell; 2017 Jul; 67(2):252-265.e6. PubMed ID: 28689661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity.
    Yu L; Wei W; Lv J; Lu Y; Wang Z; Cai C
    Cancer Lett; 2024 Nov; 604():217271. PubMed ID: 39306229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy.
    He J; Lee HJ; Saha S; Ruan D; Guo H; Chan CH
    Cell Death Dis; 2019 Mar; 10(4):285. PubMed ID: 30918246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells.
    Sulaiman A; McGarry S; Chambers J; Al-Kadi E; Phan A; Li L; Mediratta K; Dimitroulakos J; Addison C; Li X; Wang L
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.
    Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
    J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
    Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
    Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
    Doherty MR; Parvani JG; Tamagno I; Junk DJ; Bryson BL; Cheon HJ; Stark GR; Jackson MW
    Breast Cancer Res; 2019 Apr; 21(1):54. PubMed ID: 31036052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.